What Researchers Did
Researchers reviewed various medical treatments for hidradenitis suppurativa (HS) based on their experience with over 350 patients.
What They Found
The review found that mild hidradenitis suppurativa (HS) can often be treated with topical clindamycin and dapsone. For Stage 1 and 2 HS, a combination of rifampin with oral clindamycin or minocycline is a first-line treatment, while severe HS often requires stronger medications like cyclosporine, adalimumab, or infliximab at double psoriatic doses. Other treatments discussed included various antibiotics, hormone blockers, and surgical options like CO2 laser ablation and 1064 nm laser for hair removal.
What This Means for Canadian Patients
Canadian patients with hidradenitis suppurativa (HS) can discuss a range of medical and surgical treatment options with their healthcare providers, from topical creams for mild cases to advanced biologics for severe disease. This review highlights the importance of tailoring treatment based on the severity and specific presentation of HS, offering a practical guide for managing this challenging condition.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This review synthesizes existing knowledge and the author's clinical experience rather than presenting new data from a controlled clinical trial.